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a b s t r a c t
In vertebrates, pre-placodal ectoderm and neural crest development requires morphogen gradients and
several transcriptional factors, while the involvement of histone modiﬁcation remains unclear. Here, we
report that histone-modifying factors play crucial roles in the development of pre-placodal ectoderm
and neural crest in Xenopus. During the early neurula stage, PRDM12 was expressed in the lateral pre-
placodal ectoderm and repressed the expression of neural crest speciﬁer genes via methylation of
histone H3K9. ChIP-qPCR analyses indicated that PRDM12 promoted the occupancy of the trimethylated
histone H3K9 (H3K9me3) on the Foxd3, Slug, and Sox8 promoters. Injection of the PRDM12 MO inhibited
the expression of presumptive trigeminal placode markers and decreased the occupancy of H3K9me3 on
the Foxd3 promoter. Histone demethylase Kdm4a also inhibited the expression of presumptive
trigeminal placode markers in a similar manner to PRDM12 MO and could compensate for the effects
of PRDM12. ChIP-qPCR analyses revealed that promotion of the occupancy of H3K9me3 on the Foxd3,
Slug, and Sox8 promoters was inhibited by Kdm4a overexpression. Taken together, these data indicate
that histone modiﬁcation was essential for pre-placodal ectoderm and neural crest development.
& 2015 Elsevier Inc. All rights reserved.
Introduction
In the vertebrate embryo, the neural plate border is thought to
be formed by the intermediate activation of bone morphogenetic
protein (BMP) signaling to induce several neural plate border genes
(Dincer et al., 2013; Reichert et al., 2013; Tribulo et al., 2003). The
border region then further separates into the pre-placodal ectoderm
and neural crest, with the former segregating into individual cranial
placodes, such as the adenohypophyseal, olfactory, lens, trigeminal,
lateral line, otic, and epibranchial placodes (reviewed in Baker and
Bronner-Fraser, 2001; Saint-Jeannet and Moody, 2014; Schlosser,
2010). In contrast, the neural crest differentiates into the peripheral
nervous system, adrenal medulla, melanocytes, facial cartilage, and
tooth dentine (reviewed in Grenier et al., 2009; Minoux and Rijli,
2010; Steventon et al., 2014; Theveneau and Mayor, 2012).
Pre-placodal ectoderm development requires the expression of
a neural plate border gene, Dlx3 (Hans et al., 2004; Kaji and
Artinger, 2004; Woda et al., 2003). Dlx3 is regulated by BMP
signaling and promotes the expression of pre-placodal ectoderm
speciﬁer genes such as Six1 and Eya1, known as pan-placodal
markers (Woda et al., 2003). A recent study also indicated that
Dlx3 expression in nonneural ectoderm was required for acquiring
the competence to form pre-placodal ectoderm (Pieper et al.,
2012). Indeed, Dlx3 overexpression reduced the expressions of
neural plate genes, neural plate border genes, and neural crest
genes, whereas the injection of Dlx3 morpholino oligomer (MO)
expanded their expression (Pieper et al., 2012).
On the other hand, a previous report showed that a neural plate
border gene, Msx1, was important for neural crest speciﬁcation
(Monsoro-Burq et al., 2005). A gain-of-function experiment using
the Msx1-GR construct showed that Msx1 could induce the
expression of several neural crest speciﬁer genes (Tribulo et al.,
2003). Another study suggested that some neural crest cells could
be induced by co-expression of Msx1 and Pax3 in Xenopus animal
cap cells in the presence of Wnt and ﬁbroblast growth factor (FGF)
signaling (Monsoro-Burq et al., 2005). In the animal cap cells
injected with Noggin, Msx1 overexpression could also activate the
expression of Pax3 and Zic1, which play important roles in the
induction and formation of functional neural crest cells (Milet
et al., 2013; Monsoro-Burq et al., 2005; Sato et al., 2005).
A boundary formation between the pre-placodal ectoderm and
neural crest may rely on the expression levels of Dlx and Msx,
whose proteins can bind to each other and form an inhibitory
complex (Zhang et al., 1997). Pre-placodal ectoderm genes could
be induced by the high transcriptional activity of Dlx (Pieper et al.,
2012), whereas neural crest genes were induced by that of Msx
(Monsoro-Burq et al., 2005). These mutual inhibitions may con-
tribute to the boundary formation between early pre-placodal
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ectoderm and neural crest. However, a recent study showed that
neural crest region did not expand to the pre-placodal ectoderm
region in the embryo injected with Dlx3 MO (Pieper et al., 2012),
and thus another mechanism likely determines the boundary.
A recent study implicated the epigenetic factor Kdm4a, which
acts as a histone demethylase, was expressed in the neural crest
region of chick embryos (Strobl-Mazzulla et al., 2010). We hypothe-
sized that histone modiﬁcation for transcriptional regulation was
required for pre-placodal ectoderm and neural crest patterning, and
focused on histone-modifying enzymes expressed in pre-placodal
ectoderm. To investigate which histone methyltransferases could be
involved with pre-placodal ectoderm development, we performed a
β-catenin-dependent microarray analysis (Tanibe et al., 2008) and
identiﬁed PRDM12, a member of the PRDM family of histone
methyltransferase factors. PRDM12 was expressed in the parietal
region of the central nervous system and cranial placode in
zebraﬁsh and mouse embryos (Kinameri et al., 2008; Sun et al.,
2008), and regulated cell proliferation in P19 cells (Yang and
Shinkai, 2013). However, the importance of PRDM12 in embryonic
development remains largely unknown. In this study, we demon-
strate the role of PRDM12 during early Xenopus development and
the requirement of histone modiﬁcation by PRDM12 and Kdm4a for
pre-placodal ectoderm and neural crest development.
Results
PRDM12 is expressed in the lateral pre-placodal ectoderm after the
gastrula stage and is regulated by BMP and late Wnt signaling
First, the expression of Xenopus PRDM12 was investigated by
reverse transcription-polymerase chain reaction (RT-PCR) and
whole-mount in situ hybridization (WISH) analyses. PRDM12 was
zygotically expressed after the late gastrula stage (Fig. 1A) and was
detected at the lateral pre-placodal ectoderm in the early neurula
embryo (Fig. 1B). In the mid-neurula stage, PRDM12 expression
was also observed in the two stripes of neural plate (Fig. 1C) and
was partially co-localized with the lateral expression regions of
Six1, Pax3, Islet1, and Pax6 (Fig. 1D and E; Supplementary Fig. S1A–
C), but not Foxd3 and Six3 (Fig. 1F and G; Supplementary Fig. S1D).
Wnt and BMP signaling alter the expression of pre-placodal
ectoderm and neural crest genes (Matsuo-Takasaki et al., 2005;
Sato et al., 2005). To test whether these signals also regulated
PRDM12 expression, PRDM12 expression in the embryos regulating
the signals was investigated. In embryos injected with Chordin,
PRDM12 was ectopically expressed in the ventral epidermal region
(ectopic expression in 79%, n¼29; Fig. 1H, J and L). In contrast,
BMP4 overexpression resulted in increased PRDM12 expression
(increase in 96%, n¼28; Fig. 1N). In the posteriorized embryo
injected with pCS2-Wnt3a, the expression of PRDM12 was
repressed in the anterior region (repression in 96%, n¼28;
Fig. 1P), whereas anteriorized embryos injected with Dkk1 mRNA
showed increased PRDM12 expression toward the posterior
(increase in 93%, n¼27; Fig. 1R). These effects were similar to
those of Pax3 (Fig. 1I–S), a neural plate border speciﬁer gene
(Plouhinec et al., 2013). Our data indicated that PRDM12 expres-
sion was regulated by both BMP and Wnt signaling in Xenopus
embryos.
PRDM12 overexpression inhibits neural crest formation via the
trimethylation of histone H3K9
Gain-of-function experiments were performed to clarify the
role of PRDM12 in early Xenopus development. Injection of
PRDM12 into the animal pole of two-cell-stage embryos caused
small head formation and defective melanocytes (suppression of
53%, n¼49; compare Fig. 2B with C). As melanocytes are derived
from neural crest cells, whether the injection of PRDM12 also
inhibited early neural crest differentiation was tested. At the early
neurula stage, PRDM12 overexpression signiﬁcantly reduced the
expression of several neural crest markers such as Foxd3, Slug, and
Sox9 (repression in 73%, n¼26, 75%, n¼36, 67%, n¼24, respec-
tively Fig. 2D–I), whereas expression patterns of the pre-placodal
markers Islet1 and Six1, and neural marker Sox2, were not affected
(no repression in 86%, n¼22, 94%, n¼33, 95%, n¼21, respectively
Fig. 2J–O). A recent study revealed that neural crest cells were
induced by both antagonizing BMP and promoting late Wnt
signaling (Sato et al., 2005). Thus, neural crest cell induction can
be mimicked by co-injection of Chd and Wnt8 mRNAs in animal
cap cells (Sato et al., 2005). RT-PCR indicated that PRDM12 over-
expression in Chd- and Wnt8-injected animal cap cells inhibited
the expression of several neural crest markers in a dose-
dependent manner (Fig. 2P, lanes 4–6). PRDM12 contains a PR/
SET domain that is probably related to histone methylation and
multiple zinc-ﬁnger domains (Fig. 2A). Generally, histone methyl-
transferase acts either as a positive regulator of transcription by
methylating histone H3 at lysine 4 (H3K4) or as a negative
regulator via methylation of histone H3 at lysine 9 (H3K9) or
lysine 27 (H3K27) (reviewed in Zentner and Henikoff, 2013). To
test whether PRDM12 acts as a positive or negative regulator,
Western blotting analysis using each anti-trimethylated lysine
antibody was performed, which indicated that PRDM12 induced
the trimethylation of H3K9 (H3K9me3) in a dose-dependent
manner, but not H3K4 and H3K27 (Fig. 2Q). These results demon-
strated that PRDM12 played an inhibitory role in neural crest gene
expression and promoted the H3K9me3. Following a previous
study (de Souza et al., 1999), two fusion constructs, VP16-PRDM12
and EnR-PRDM12, were made (Supplementary Fig. S2A). Micro-
injection with VP16-PRDM12 increased the number of melanocytes
and induced several neural crest markers in animal cap cells
(Supplementary Fig. S2B, C and F). In contrast, EnR-PRDM12
decreased pigmentation and repressed several neural crest mar-
kers in Chd- and Wnt-injected animal cap cells, as observed in the
embryos or animal cap cells injected with PRDM12-WT (Supple-
mentary Fig. S2D, E and G). Because the effects of EnR-PRDM12
were similar to those of PRDM12-WT, PRDM12 could act as a
negative regulator for the target gene transcription. These ﬁndings
showed that the zinc-ﬁnger domains of PRDM12 were required for
its repression activity.
PRDM12 promotes the occupancy of H3K9me3 on the Foxd3, Slug,
and Sox8 promoters
Based on the high levels of conservation of the PRDM12 zinc-
ﬁnger domains (Supplementary Fig. S3), we hypothesized that a
target sequence of PRDM12 would also be conserved. Using the
VISTA browser, a conserved noncoding sequence (CNS) around
several neural crest genes was sought by comparing 7 kb of each
genomic region among Xenopus and other species. In the upstream
region of Foxd3, a 48-bp CNS (Fig. 3A) was identiﬁed. To test
whether this sequence actually functioned, luciferase reporter
assays were performed using the Foxd3 promoter fragment includ-
ing the CNS region. When this pFoxd3-2000-luc construct was
injected dorsally, high luciferase activity was observed (Fig. 3B). To
investigate whether the inhibition of Foxd3expression by PRDM12
overexpression was dependent on the CNS in the Foxd3 promoter,
a further luciferase assay was performed using each deletion
construct. When pFoxd3-2000-luc or pFoxd3-1647-luc was co-
injected with PRDM12, inhibition of luciferase activity occurred.
Conversely, in the case of co-injection of the other constructs and
PRDM12, luciferase activity was recovered (Fig. 3C), suggesting
that the inhibition of Foxd3 transcription by PRDM12 was
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Fig. 1. Histone methyltransferase PRDM12 is expressed in the lateral pre-placodal ectoderm and regulated by Wnt and BMP signaling. (A) Stage RT-PCR analysis showing that
PRDM12 mRNA is zygotically expressed after stage 13. Chordin and ODC were used as internal controls. (B–H) WISH analysis of PRDM12 (B, C and H), Six1 (D), and Foxd3
(F) expression at the indicated embryo stages. (E and G) Double in situ hybridization revealed partial co-localization of the PRDM12 transcripts (dark blue) with Six1 transcripts
(light blue; E), but not with Foxd3 transcripts (light blue; G). The PRDM12 expression region is indicated by a red dotted outline in E and G. (H–S) Effects of BMP andWnt signaling
on PRDM12 and Pax3 expression at the neurula stage were analyzed by injecting ChordinmRNA (100 pg/embryo), BMP4mRNA (20 pg/embryo), pCS2-Wnt3a (50 pg/embryo), and
Dkk1mRNA (10 pg/embryo) into the animal pole at the two-cell stage. (H and I) Dorsal view of the control embryo. (J–M) PRDM12 and Pax3 transcripts were expressed ectopically
on the ventral side in embryos injected with Chordin mRNA (M, 76%, n¼33). (N and O) BMP4 mRNA reduced PRDM12 and Pax3 expression (O, 100%, n¼24). (P and Q)
Posteriorized embryos caused the defective expression in the anterior part (Q, 91%, n¼33). (R and S) Anteriorized embryos shifted the expression to the posterior region (S, 68%,
n¼31). YP; Yolk Plug. Scale bars represent 0.5 mm.
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Fig. 2. Injection of PRDM12 mRNA inhibits neural crest formation via trimethylation of histone H3K9. (A) The PRDM12 protein structure showing a PR/SET domain (black
box) and multiple zinc-ﬁnger domains (gray boxes). (B) A control embryo at stage 38. (C) An embryo injected with PRDM12mRNA (1000 pg/embryos) into the animal pole at
the two-cell stage showing the small head and pigmentation defects. (D–O) WISH analysis of expressed transcripts at the mid-neurula stage, with anterior views of each
embryo. (D–I) The expression of neural crest markers (Foxd3, Slug, and Sox9) was diminished in embryos injected with PRDM12 mRNA (1000 pg/embryo) at the two-cell
stage. In contrast, (J–O) the expression of the presumptive trigeminal placode (Islet1), early pan-placode (Six1), and neural marker (Sox2) remained largely unchanged. (P) RT-
PCR analysis showed that expression of the neural crest markers was decreased in a dose-dependent manner by injection of PRDM12 mRNA into Chd and Wnt8 mRNA-
injected animal caps. (Q) Western blot analysis with antibodies against trimethylated histones H3K4, H3K9, H3K27, and H3 on samples of Chd and Wnt8 mRNA-injected
animal cap cells, with and without PRDM12 mRNA. The scale bars for B and C, and D–O, represent 1 mm and 0.5 mm, respectively.
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dependent on the Foxd3 CNS. To investigate whether PRDM12
actually bound to the CNS and methylated histone H3K9 around
the Foxd3 promoter, chromatin immunoprecipitation-quantitative
PCR (ChIP-qPCR) analyses were performed with anti-myc and anti-
H3K9me3 antibodies. Injection of myc-PRDM12 followed by ChIP
analysis with anti-myc antibody showed high occupancy of myc-
PRDM12 in the CNS of the Foxd3 promoter, whereas the occupancy
of myc-PRDM12 at the 1.0 kbp, 0.5 kbp, and 0 kbp regions
from the Foxd3 transcriptional start site did not increase (Fig. 3D).
ChIP analyses with an anti-H3K9me3 antibody showed increase
occupancy of H3K9me3 in the Foxd3 promoter by PRDM12 over-
expression (Fig. 3E). These results suggested that PRDM12 bound
to the CNS of Foxd3 and promoted the trimethylation of H3K9
around the Foxd3 promoter region. Moreover, an electrophoretic
mobility shift assay (EMSA) to investigate the binding activity of
PRDM12 to the CNS region showed a band shift of the CNS probe
in those extracts containing myc-PRDM12 (Supplementary Fig.
S4A and B), but not in those from embryos injected with PRDM12
depleted zinc-ﬁnger domains (PRDM12ΔZNF) (Supplementary Fig.
S4B, lane 1). Further research investigated whether PRDM12
promoted the occupancy of H3K9me3 at another neural crest
speciﬁer gene promoter. ChIP-qPCR analyses using an anti-
H3K9me3 antibody showed that injection of PRDM12 increased
the occupancy of H3K9me3 at Slug, Sox8, Sox9, and Sox10, whereas
those of Twist and Six1 were not affected (Fig. 3H; Supplementary
Fig. S5). In particular, the occupancy of H3K9me3 around the Slug
and Sox8 promoters was signiﬁcantly changed by PRDM12 over-
expression (Fig. 3F and G). These results conﬁrmed that PRDM12
promoted the occupancy of H3K9me3 on the neural crest speciﬁer
gene promoters.
Knockdown of PRDM12 inhibits the expression of presumptive
trigeminal placode markers and expands the neural crest region
To assess the requirement for PRDM12 function during early
development, an antisense MO was designed to knockdown
PRDM12 (Supplementary Fig. S6). Embryos injected with the
PRDM12 MO into one side of each blastomere at the four-cell
Fig. 3. PRDM12 promotes trimethylation of H3K9 on Foxd3 promoter regions through binding the CNS. (A) VISTA view of the conserved sequence domains in the genomic
region containing the Foxd3 gene. Colored peaks indicate regions of at least 100 bp and with 60% similarity [dark blue, exons; light blue, untranslated regions (UTRs); pink,
noncoding regions]. One conserved noncoding sequence (CNS) is shown. (B and C) Luciferase assays using the indicated Foxd3 promoter region. Expression levels were
normalized to Renilla luciferase. Error bars represent 7S.D. (n¼3). (B) Luciferase assays on stage 20 embryos that were co-injected at the four-cell stage with pGL3-Control
or pFoxd3-2000-luc and pGL-TK (Renilla luciferase vector) into the dorsal or ventral side. (C) The indicated luciferase reporter vector and PRDM12 mRNA were co-injected
into the dorsal side of four-cell-stage embryos, which were harvested after injection and subjected to relative luciferase activity measurement. (D–H) ChIP-qPCR analysis
using the Chd and Wnt8 mRNA-injected animal cap cells co-injected with or without myc-PRDM12 mRNA. The vertical axes represent the percentage input (ChIP enriched/
input) and the horizontal axes represent the approximate distance from the transcriptional start site (TSS) of each gene. ChIP-qPCR analyses were performed with an anti-
myc antibody (D) or anti-H3K9me3 antibody (E–H). The Six1 promoter region (0.5 kbp from the TSS) was used as a negative control. Error bars indicate 7S.E. (n¼3).
Differences were considered to be statistically signiﬁcant at pr0.05(*) or pr0.01(**) by Student’s t-test.
Fig. 4. PRDM12 MO represses the trigeminal placode markers via trimethylation of histone H3K9 on the Foxd3 promoter. (A–E) WISH analysis using the indicated probes.
Anterior views of mid-neurula embryos injected with Control MO (20 ng/embryo) or PRDM12 MO (20 ng/embryo) and lacZ mRNA (0.1 ng/embryo) with or without
misPRDM12 mRNA (1 ng/embryo) into one side of each blastomere at the four-cell stage. (A–C) Expression of the presumptive trigeminal placode markers (Ath3, EBF3, and
Islet1) decreased in the PRDM12 MO-injected embryo, whereas the reduction of these markers was rescued by injection of morpholino-resistant PRDM12 (misPRDM12). In
contrast, (D and E) expression of the early pan-placodal marker (Six1) and the neural marker (Sox2) were unchanged. (F) Quantitation of the phenotype percentage in the
embryos injected with MOs and mRNA. The injected embryos separated into two phenotypes (no effect or severe defect). Quantiﬁcation of PRDM12 MO- and misPRDM12
mRNA-injected embryos in Ath3 (n¼24), EBF3 (n¼28), Islet1 (n¼25) compared with PRDM12 MO-injected embryos at neurula stage. po0.0005 by the chi-square test. (G
and H) Control MO or PRDM12 MO and lacZ mRNA (0.1 ng/embryo) were sequentially injected into one side of the blastomere from the four-cell to the eight-cell stage. The
Slug expression region was expanded anteriorly on the injected side (P, no effect in 100%, n¼27). Scale bars represent 0.5 mm. (I–L) Reverse transcription–quantitative
polymerase chain reaction (RT-qPCR) analysis of Ath3 (I), Foxd3 (J), Slug (K), and Sox2 (L) expression was performed on late neurula-stage embryos injected with PRDM12 MO
into the animal blastomeres at the four-cell stage. (M and N) ChIP-qPCR analyses of the Foxd3 and Six1 promoter sites were performed using an anti-H3K9me3 antibody.
Embryos injected with Control MO or PRDM12 MO were cultured until stage 15, and the pre-placodal ectoderm region was dissected. Error bars indicate 7S.E. (n¼3).
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stage showed that the expression levels of presumptive trigeminal
placode markers such as Ath3 (Fig. 3A), EBF3 (Fig. 4B), and Islet1
(Fig. 4C) were markedly diminished at the neurula stage, whereas
the expression levels of Six1 (Fig. 4D) and Sox2 (Fig. 4E) were not
affected. A comparison between the effects of PRDM12 MO
injection and those of PRDM12 MO and misPRDM12 co-injection
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showed that the reduction of presumptive trigeminal placode
marker expression by PRDM12 MO was rescued by co-injection
of misPRDM12 (Fig. 4F). These results suggested that PRDM12 was
required for presumptive trigeminal placode development. To
investigate whether knockdown of PRDM12 also affected neural
crest formation, WISH analysis was performed on embryos
injected with PRDM12 MO and lacZ into one side. A comparison
of the PRDM12 MO-injected side with the uninjected side revealed
an anterior expansion of the Slug expression region (expansion
in 61%, n¼28; Fig. 4G and H). RT-qPCR analysis showed that
expression of Ath3decreased in a dose-dependent manner (Fig. 4I),
whereas those of Foxd3 and Slug increased (Fig. 4J and K) and
Sox2 expression remained unaffected (Fig. 4L). ChIP-qPCR analysis
using an anti-H3K9me3 antibody revealed that the occupancy of
H3K9me3 on the Foxd3 promoter, but not on the Six1 promoter,
decreased in embryos injected with PRDM12 MO (Fig. 4M
and N). These results suggested that PRDM12 contributed to the
regionalization of the pre-placodal ectoderm by inhibiting the
expression of several neural crest genes.
Kdm4a overexpression produces a similar effect to injection of
PRDM12 MO that can be rescued by PRDM12
A recent study revealed that demethylase Kdm4a/Jmjd2a was
important for neural crest speciﬁcation in chick development
(Strobl-Mazzulla et al., 2010). Kdm4a contains a jumonji domain
required for methyl lysine-speciﬁc demethylation activity on
histones H3K9 and H3K36. Thus, we speculated that pre-
placodal ectoderm and neural crest patterning also required the
expression of Kdm4a. RT-PCR and WISH analysis showed that
Kdm4a was maternally expressed in the animal hemisphere at the
early blastula stage (Supplementary Fig. S7A and B). At the neurula
stage, Kdm4a expression was observed at the neural plate, neural
plate border, and neural crest, including the trunk neural crest
region (Supplementary Fig. S7C and D). These expression patterns
are similar to that of chick Kdm4a (Strobl-Mazzulla et al., 2010).
When Kdm4a was injected into the animal pole of two-cell-stage
embryos, Ath3 and Islet1 expression was not detected in the
presumptive trigeminal placode region, as observed in the
embryos injected with PRDM12 MO (suppression in 73%, n¼33,
69%, n¼32, respectively Fig. 5A, B, E and F). Notably, the expres-
sion of Ath3 and Islet1 was rescued by co-injection of PRDM12 (no
suppression in 78%, n¼23, 83%, n¼18, respectively Fig. 5B–D and
F–H). Furthermore, the expression of Foxd3 and Slug did not
decrease in the embryos injected with Kdm4a (no suppression in
84%, n¼32, 94%, n¼33, respectively Fig. 5I, J, M and N), whereas
the inhibition of neural crest markers by PRDM12 overexpression
was rescued by co-injection with Kdm4a (no suppression in 80%,
n¼20, 95%, n¼19, respectively; Fig. 5I–P). In contrast, Sox2
expression was largely unaffected (96%, n¼28, 92%, n¼24, 96%,
n¼25, respectively Fig. 5Q–T). Because the embryos injected with
PRDM12 MO and Kdm4a showed similar phenotypical effects, we
assumed that Kdm4a overexpression could cause anterior expan-
sion of the neural crest region, as observed in the PRDM12 MO-
injected embryos. To test this hypothesis, WISH analyses were
performed using embryos injected with Kdm4a and lacZ mRNAs
into one side. Comparison of the Kdm4a-injected side with the
uninjected side revealed an anterior expansion of Foxd3 and Slug
expression (expansion in 64%, n¼28, 59%, n¼27, respectively
Fig. 5U–X). Furthermore, the inhibition of several neural crest
markers by microinjection of PRDM12 was rescued by co-injection
with Kdm4a in the animal cap cells (Fig. 6A). In the luciferase assay
using pFoxd3-2000-luc, luciferase activity was weakly enhanced
in the embryos injected with Kdm4a (Fig. 6B). Meanwhile, the
repression of luciferase activity by the PRDM12 injection was
partially rescued by Kdm4a (Fig. 6C). Moreover, ChIP-qPCR
analyses showed that the high occupancy of H3K9me3 on the
Foxd3, Slug, and Sox8 promoters, but not the Six1 promoter, was
suppressed by Kdm4a co-injection (Fig. 6D–G). The dual PHD and
Tudor domains of Kdm4a are known to be selective for binding
trimethylated H3K4 (H3K4me3) and H4K20 (Huang et al., 2006;
Lee et al., 2008). Thus, we investigated the endogenous methyla-
tion levels by ChIP-qPCR using anti-H3K4me3 and anti-H3K9me3
antibodies. In the neural plate border dissected from gastrula
embryos, occupancy of H3K4me3 on the Foxd3 promoter was
observed (Fig. 7A), whereas none was detected on H3K9me3
(Fig. 7B). Moreover, the occupancy of H3K9me3 on this promoter
increased in the dissected pre-placodal ectoderm at the neurula
stage (Fig. 7C), but not in the dissected neural crest (Fig. 7D). These
ﬁndings suggested that modiﬁcation of histone H3K9 on the Foxd3
promoter, which is a common target for PRDM12 and Kdm4a, was
required for pre-placodal ectoderm and neural crest development.
Discussion
In this study, we showed that histone modiﬁcation in the
neural crest gene promoters contributed to pre-placodal ectoderm
and neural crest patterning. Speciﬁcally, we found that PRDM12,
expressed in the lateral pre-placodal ectoderm, inhibited neural
crest formation by promoting histone H3K9me3 on the Foxd3, Slug,
and Sox8 promoters. This H3K9me3 is known to promote chro-
matin remodeling to form a silent heterochromatin with hetero-
chromatin protein 1 (HP1), an important factor for the recruitment
of other remodeling factors (Bannister et al., 2001; Jacobs and
Khorasanizadeh, 2002; Lachner et al., 2001). Thus, aggregated
structures of heterochromatin induced by the H3K9me3 on these
gene promoters would inhibit the transcriptional activity of these
genes in the pre-placodal ectoderm (Fig. 7E, left). Conversely,
Kdm4a likely recognized, bound to histone H3K4me3 on the Foxd3
promoter, and reduced methylation levels of H3K9 to promote the
expression of neural crest speciﬁer genes in the neural crest cells
(Fig. 7E, right). In short, modiﬁcation of the methylation levels of
histone H3K9 on the neural crest gene promoter by PRDM12 and
Kdm4a determined a boundary between the pre-placodal ecto-
derm and the neural crest region. Moreover, we demonstrated that
PRDM12 knockdown inhibited the presumptive trigeminal pla-
code formation in a similar manner to Kdm4a overexpression. In
chick development, Kdm4a knockdown inhibits the expression of
several neural crest genes (Strobl-Mazzulla et al., 2010) in a
manner similar to the PRDM12 overexpression seen in our study.
PRDM12 and Kdm4a exhibit a complementary effect in histone
modiﬁcation of the neural crest gene promoter.
Dimethylation of H3K9 can recruit HP1 (Bannister et al., 2001;
Lachner et al., 2001). Furthermore, proteins containing a SET
domain can regulate multiple types of methylation. For example,
Dim-5 regulates mono-, di-, and trimethylation of histone H3K9
(Collins et al., 2009). If the PR/SET domain of PRDM12 were
capable of another methylation activity such as Dim-5, PRDM12
could also have modiﬁcation activities to promote mono- and
dimethylation of histone H3K9. To evaluate these activities, Wes-
tern blotting and ChIP-qPCR analysis with antibodies against
H3K9me1 or H3K9me2 should be performed.
We showed that injection of PRDM12 MO or Kdm4a caused
inhibition of the presumptive trigeminal placode gene expression
at the early neurula stage and decreased the occupancy of
H3K9me3 on the neural crest gene promoter. These data indicate
that PRDM12 and Kdm4a can indirectly regulate pre-placodal
ectoderm development by regulating the expression of neural
crest genes. A previous study showed that Foxd3 overexpression
could inhibit the posterior placode formation including the pre-
sumptive trigeminal placode at the early neurula stage (Brugmann
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Fig. 5. Overexpression of Kdm4a causes a defect of the presumptive trigeminal placode and rescues the repression of neural crest formation by PRDM12. (A–T) WISH analyses using
the indicated transcripts. Anterior view of the embryos. (A, E, I, M and Q) Control embryos. (B, F, J, N and R) Embryos injected with Kdm4amRNA (200 pg/embryo) or (C, G, K, O and
S) PRDM12 mRNA (1000 pg/embryo) or (D, H, L, P and T) Kdm4a and PRDM12 mRNAs into the animal poles at the two-cell stage were harvested until stage 15. (A–H) Yellow
arrowheads indicate the expression of the trigeminal placode markers Ath3 and Islet1. The expressionwas reduced by overexpression of Kdm4amRNA but not by PRDM12mRNA (C,
93%, n¼28; G, 86%, n¼35). The reduction of Ath3 and Islet1 was rescued by co-injection with PRDM12mRNA. (I–P) The expression of the neural crest markers Foxd3 and Slugwas
not repressed by injection of Kdm4amRNA, whereas these markers were suppressed by injection of PRDM12 mRNA (K, 53%, n¼45; O, 55%, n¼42). The repression of neural crest
markers by PRDM12 mRNA was also rescued by Kdm4a overexpression. (Q–T) The expression of the neural plate marker Sox2 was largely unaffected. (U–X) WISH analyses using
embryos injected with lacZmRNA (100 pg/embryo) with or without Kdm4amRNA into one side at the four-cell stage showing the expression of Slug and Foxd3. (U and W) Control
embryos (no expansion in 92%, n¼25, 96%, n¼28, respectively). (V and X) Expansion of Slug and Foxd3 expression in the injected side was observed. Scale bars represent 0.5 mm.
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et al., 2004). We also demonstrated that expression of the neural
crest markers expanded to a section of the pre-placodal ectoderm
region in embryos injected with PRDM12 MO or Kdm4a mRNA;
thus, the knockdown of PRDM12 and the ectopic expression of
Kdm4a could allow Foxd3 expression at the presumptive trigem-
inal placode region, and the expression of the presumptive
trigeminal placode genes would be repressed by Foxd3. However,
the expansion of the neural crest markers by Kdm4a overexpres-
sion was weaker than that by PRDM12 knockdown, which might
indicate that PRDM12 and Kdm4a utilize different mechanisms to
regulate histone modiﬁcation. For demethylation on the neural
crest gene promoter, Kdm4a had to recognize H3K4me3 to bind to
the gene promoter. In the pre-placodal ectoderm cells, the occu-
pancy of H3K4me3 could be decreased by another histone-
modifying enzyme. Ectopic Kdm4a would fail to bind to these
gene promoters and would not demethylate histone H3K9.
Another histone-modifying enzyme could be related to the devel-
opmental patterning of the pre-placodal ectoderm and
neural crest.
Luciferase analyses using the Foxd3 promoter fragment showed
that PRDM12 overexpression could repress luciferase activity and
that this was dependent on the CNS of the Foxd3 promoter.
However, whether histone proteins directly bind to exogenous
DNA to form a proper histone–DNA complex such as a nucleosome
remains unclear. A recent study revealed that histone demethylase
LSD1 could repress luciferase expression in a demethylation
activity-dependent fashion (Shi et al., 2004), suggesting that
PRDM12 also methylates histone proteins bound to the injected
DNA and promotes the aggregation of these complexes as hetero-
chromatin in vivo.
Our results showed that microinjection of PRDM12 caused a
reduction in neural crest gene expression, whereas an expansion
of the pre-placodal ectoderm and neural plate genes was not
observed. However, several studies related to ectodermal pattern-
ing indicated that repression of one domain caused the expansion
of the adjacent domain: inhibition of neural crest formation
caused the expansion of pre-placodal ectoderm or neural plate
regions to the neural crest region (Bellmeyer et al., 2003;
Brugmann et al., 2004). For speciﬁc inhibition of neural crest
genes, other histone-modifying enzymes could be required.
PRDM12 can bind histone methyltransferase G9a/EHMT2 through
its zinc-ﬁnger domains (Yang and Shinkai, 2013). G9a, which is
widely expressed in many tissues, plays an important role in the
recruitment of other histone-modifying factors (Ling et al., 2012;
Milner and Campbell, 1993). It can bind DNA methyltransferases
Dnmt3a and G9a, with the former cooperatively regulating neu-
ronal differentiation, including the peripheral nervous system (Rai
et al., 2010). Dnmt3a is known to act as a molecular switch for
neural crest formation by inhibiting the expression of Sox2 and
Sox3 in the neural plate border cells (Hu et al., 2012), but whether
G9a and Dnmt3a are expressed in the early Xenopus embryo is not
yet known. However, if G9a and Dnmt3a are expressed at the late
gastrula stage, PRDM12 could form an inhibitory complex with
G9a and Dnmt3a, and that complex could repress the expression
of neural crest and neural plate genes. A previous study showed
that nonneural and neural competence in ectodermal cells was
restricted by some transcriptional factors such as Dlx3 and Sox3
until the late gastrula stage (Pieper et al., 2012). After loss of the
nonneural competence in the neural crest region, Six1 expression
might not be able to expand into the neural crest region.
Fig. 6. Kdm4a overexpression compensated for the effects of PRDM12 via demethylation of H3K9 on the neural crest genes promoter. (A) RT-PCR analysis of neural crest
marker expression in the animal cap cells injected with Wnt8 and Chordin mRNAs (each at 50 pg/embryo), with or without PRDM12 and Kdm4a mRNA. (B, C) Luciferase
assays on embryos injected with pFoxd3-2000-luc (30 pg/embryo), pGL-TK (10 pg/embryo), and Kdm4a mRNA (0, 50, 100, 200 pg/Sembryo) into the dorsal side at the four-
cell stage. Protein was prepared from the injected embryos at stage 18. Error bars indicate 7S.D. (n¼3). (D–G) ChIP-qPCR using an anti-H3K9me3 antibody was performed
with the Chd and Wnt8 mRNA-injected animal caps with or without injection of PRDM12 mRNA or PRDM12 and Kdm4a mRNAs. The Six1 promoter was used as a negative
control. Error bars indicate 7S.E. (n¼3).
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We showed that injection of PRDM12 MO or Kdm4a mRNA
caused speciﬁc inhibition in the expression of the presumptive
trigeminal placode markers but not the pan-placode marker.
Differentiation of neural cells is known to require dynamic histone
modiﬁcation to obtain individual neural cell fates (reviewed in
Hirabayashi and Gotoh, 2010). Thus, we hypothesize that the
expression of the neurogenic placode, including the trigeminal
placode but not pan-placode, is also regulated by histone
modiﬁcation. Development of the neurogenic placode might be
dependent on the regulation of other histone-modifying enzymes
as well as PRDM12.
Analyzing the relationship between PRDM12 and other
histone-modifying enzymes would be of interest in future ana-
lyses. For example, PRDM2, which is a member of the PRDM
family, can regulate the methylation of histone H3K9 for transcrip-
tional repression of several genes and act as a transcriptional
Fig. 7. The occupancy of H3K4me3 and H3K9me3 in the indicated tissues and a model of pre-placodal ectoderm and neural crest development. (A–D) ChIP-qPCR analyses
using mock antibody, anti-H3K4me3, or anti-H3K9me3 on the indicated tissues. Each tissue was obtained using 100 dissected embryos at each stage. (E) The model of pre-
placodal ectoderm and neural crest patterning based on our ﬁndings. Occupancy of H3K9me3 on the Foxd3 promoter is not observed in the neural plate border, whereas that
of H3K4me3 is apparent. In the pre-placodal ectoderm, PRDM12 is expressed and speciﬁcally promotes the trimethylation of H3K9 on the Foxd3 promoter to bind at the CNS.
A chromatin remodeling factor, HP1, recognizes the trimethylation of H3K9 and recruits other factors to convert euchromatin to heterochromatin. In contrast, in the neural
crest region, Kdm4a is expressed to maintain the demethylation of H3K9 on the Foxd3 promoter and bind to the trimethylated H3K4.
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activator to bind p300, known as an acetyltransferase (Carling et
al., 2004; Kim et al., 2003). PRDM12 may therefore upregulate
placode speciﬁer genes together with a histone-modifying enzyme
to promote placode formation. PRDM12 can also repress cell
proliferation by modulating the cell cycle in P19 nerve cells and
acts as a putative tumor suppressor for chronic myeloid leukemia
(Reid and Nacheva, 2004; Yang and Shinkai, 2013). Kdm4a also
regulates several genes related to cell proliferation and contributes
to breast tumor formation (Berry et al., 2012; Kim et al., 2012).
Based on these ﬁndings, the mutual relationship between PRDM12
and Kdm4a may contribute to other biological events.
Materials and methods
DNA construction
PRDM12 cDNA was inserted into an EcoRV-digested pBlue-
script-SK or EcoRV-digested pCS2-myc vector (Danno et al.,
2008). A long PCR was then carried out to generate morpholino-
resistant PRDM12 constructs by replacing the sequence for binding
the antisense morpholino from GAATTAATGATGGGCTCGGTGCTGC
to GAGCTCATGATGGGAAGTGTATTA (Fig. S6A). A deletion mutant-
PRDM12 was generated by a long PCR. Foxd3, Islet1, and Kdm4a
cDNAs were inserted into a StuI-digested pCS2p vector. For WISH,
PRDM12, Sox9, and Pax3 cDNAs were inserted into an EcoRV-
digested pBluescript-SK vector, and pBluescript-SK-Six1 was
digested with EcoRI, blunted using T4 polymerase, and then self-
ligated. For the luciferase assays, a Foxd3 promoter fragment
ampliﬁed by PCR in Xenopus laevis genomic DNA was inserted
into a pGL3 vector (Promega, Madison, WI, USA). To generate
several Foxd3 promoter reporter constructs, pFoxd3-1647-luc,
pFoxd3-1612-luc, pFoxd3-1577-luc, and pFoxd3-1000-luc were
obtained by PCR, and pFoxd3-1504-luc and pFoxd3-1195-luc were
digested with PstI and EcoRV, blunted with T4 polymerase, and
then self-ligated. The primer sequences for all the DNA construc-
tion are listed in Table S1.
Embryo manipulation
The stages of development referred to in this study are based
on the stages of normal Xenopus developmental stages
(Nieuwkoop and Faber, 1967). X. laevis embryos were obtained
by artiﬁcial fertilization and dejellied with 4.6% L-cysteine hydro-
chloride at pH 7.8. Synthetic mRNAs were prepared using the
mMESSAGE mMACHINE SP6 transcription kit (Ambion, Life Tech-
nologies, Carlsbad, CA, USA) for in vitro transcription. pCS2-
Chordin (Sasai et al., 1994), pCS2-BMP4 (Nishimatsu et al., 1992),
pCS2-Dkk1, pCS2-myc-PRDM12, pCS2-myc-PRDM12ΔZNF, pCS2-
myc-misPRDM12, pCS2p-Kdm4a, and pCS2-lacZ (Takahashi et al.,
2000) were linearized with NotI or Asp718 and transcribed with
SP6 RNA polymerase. Antisense MOs were obtained from Gene
Tools (Philomath, OR, USA). The control MO used had the follow-
ing sequence, 50-CCTCTTACCTCAGTTACAATTTATA-30, and the
sequence of the PRDM12 MO was 50-GCAGCACCGAGCCCATCAT-
TAATTC-30. Each MO was suspended in nuclease-free water (Gibco,
Life Technologies, Carlsbad, CA, USA). Synthesized mRNAs, MOs, or
expression vectors were microinjected using a PLI-100 picoinjector
(Harvard Apparatus, Holliston, MA, USA).
RNA isolation and RT-PCR or RT-qPCR
Total RNA was extracted from three embryos or 10 animal caps
using Isogen II (NIPPON Genetics, Tokyo, Japan), and cDNA was
synthesized with random primers and SuperScript III (Invitrogen,
Carlsbad, CA, USA). ODC and EF1a served as loading controls. qPCR
was performed on a StepOnePlus Real-Time PCR System (Applied
Biosystems, Foster City, CA, USA) using a KAPA SYBR Fast qPCR Kit
(NIPPON Genetics). The expression of each gene was normalized to
that of ODC. The conditions and the primer sequences for the RT-
PCR and the RT-qPCR are described in Table S2.
WISH, double in situ hybridization, and lacZ staining
To prepare the probes of each transcript, pCS2p-Kdm4a, pCS2p-
Sox9, pCS2p-Foxd3, pCS2p-Islet1, pCS2-Pax8, pBluescript-SK-
PRDM12, pBluescript-SK-Six1, pBluescript-SK-Six3, pBluescript-
SK-EBF3, pBluescript-SK-Ath3, pBluescript-SK-Pax3, pGEM-Pax6,
pGEM-Slug, and pGEM-Sox2 were linearized with each enzyme
to be used as templates, and digoxigenin (DIG)-labeled probes
were synthesized with T7 or T3 RNA polymerase (Roche, Basel,
Switzerland). WISH was carried out according to Harland (1991)
with minor modiﬁcations. For the double in situ hybridization, a
DIG-labeled probe was stained with Nitro blue tetrazolium chlor-
ide (NBT; Roche) and a ﬂuorescein-labeled probe was stained with
5-bromo-4-chloro-3-indolyl phosphate (BCIP; Roche). Before
WISH analysis, the embryos injected with LacZmRNAwere stained
with Red-gal (SAFC Biosciences Inc., Lenexa, KS, USA).
Western blotting
Cell lysates were prepared in RIPA buffer [1% NP-40, 1% sodium
deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 150 mM NaCl,
25 mM Tris–HCl, pH 7.4] with animal caps or whole embryos, and
measured using a NanoDrop 1000 (Thermo Fisher Scientiﬁc, Wal-
tham, MA, USA) with a BCA™ protein assay kit (Pierce Biotechnol-
ogy Inc., Rockford, IL, USA). Proteins were separated using 10% or
15% SDS–polyacrylamide gel electrophoresis (SDS–PAGE) gels. Wes-
tern blot analysis was performed using anti-histone H3 (Millipore,
Billerica, MA, USA; 06-755), anti-histone H3K4me3 (Abcam, Cam-
bridge, UK; ab8580), anti-histone H3K9me3 (Millipore, 07-449),
anti-histone H3K27me3 (Abcam; ab6002), anti-myc (Sigma-Aldrich,
St. Louis, MO, USA; M4439-100UL), and anti-α-tubulin antibodies
(Sigma-Aldrich; T9026-100UL).
ChIP-qPCR
For the ChIP assays, animal cap explants dissected from 100
embryos injected with each mRNA or each MO were harvested at
stage 15. The explants and embryos were cross-linked in 0.7
phosphate-buffered saline (PBS) with 1% formaldehyde and soni-
cated to digest the genomic DNA into sizes of 400–600 bp.
Samples were incubated for binding with mock control rabbit
antibody (DakoCytomation, Carpinteria, CA, USA; X0936) or target
antibodies (anti-myc, anti-H3K4me3, anti-H3K9me3) and Protein
A Sepharose Fast Flow (GE Healthcare, Buckinghamshire, UK), and
rotated overnight. The complexes were centrifuged, eluted, and
reverse cross-linked. The DNA was puriﬁed using a QIAquick
puriﬁcation cleanup kit (Qiagen, Venlo, The Netherlands). The
qPCR was performed as described previously and genomic expres-
sion was normalized to the ODC fragment. The primer sequences
are listed in Table S2.
Luciferase reporter assay and EMSA
Luciferase reporter assays were performed using the Dual-
Luciferase Reporter Assay System (Promega). To mimic the endo-
genous conditions, pGL3-control or pFoxd3-luciferase vectors
were linearized by digestion with Asp718. These vectors were
co-injected together with a Renilla luciferase plasmid (pGL-TK)
into Xenopus embryos. The injected embryos were harvested at
stage 18 and then lysed in Passive Lysis Buffer (Promega) for
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analysis using a Luminescencer-JNR (ATTO Co., Ltd., Tokyo, Japan).
EMSAs were performed using a non-radioimmunoassay (non-RI)
method. Double-stranded probes containing the putative binding
site (CNS on the Foxd3 promoter region Fig. S4A) were labeled with
DIG. Protein extracts were obtained from each mRNA-injected
animal cap and then separated on 4.5% TBE-acrylamide gels.
Western blotting was performed using anti-DIG antibody-conju-
gated horseradish peroxidase (HRP; DakoCytomation, D5101).
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